| Prev Close: | 110.63 |
|---|---|
| Open: | 111.05 |
| Bid: | 111.30 x 100 |
| Ask: | 112.23 x 100 |
| 1y Target Est: | 106.24 |
| Beta: | 0.69 |
| Next Earnings Date: | 26-Jul-13 |
| Day's Range: | 110.78 - 112.09 |
|---|---|
| 52wk Range: | 93.69 - 112.28 |
| Volume: | 483,911 |
| Avg Vol (3m): | 649,486 |
| Market Cap: | 9.00B |
| P/E (ttm): | 19.80 |
| EPS (ttm): | 5.65 |
| Div & Yield: | 0.84 (0.80%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Gloomy Prospects For Medical Device Companiesat Seeking Alpha(Sun, Jun 16)
- C.R. Bard Inc. (BCR): Today's Featured Health Services Winnerat TheStreet(Fri, Jun 14)
- A New High for CR BardZacks(Fri, Jun 14)
- Bard Increases Dividend 5%at Motley Fool(Thu, Jun 13)
- Bard Beefs Up Shareholder ReturnZacks(Thu, Jun 13)
- C.R. Bard Reaches New 52-Week High (BCR)at TheStreet(Thu, Jun 13)
- 4 Stocks Raising The Health Services Industry Higherat TheStreet(Thu, Jun 13)
- CR Bard to buyback $500M in common stockAP(Wed, Jun 12)
- After-Hours Buzz: H&R Block, Safeway, PVH & Moreat CNBC(Wed, Jun 12)
- C.R. Bard authorizes $500M stock repurchaseat theflyonthewall.com(Wed, Jun 12)
- Bard Announces $500 Million Share Repurchase AuthorizationBusiness Wire(Wed, Jun 12)
- Bard Increases Quarterly DividendBusiness Wire(Wed, Jun 12)
- Bard Begins Lutonix BTK TrialZacks(Thu, Jun 6)
- [video] Barge Into Bard, Microsoft Sharesat TheStreet(Thu, Jun 6)
- CR Bard Reiterated at NeutralZacks(Wed, Jun 5)
Press Releases
- Bard Announces $500 Million Share Repurchase AuthorizationBusiness Wire(Wed, Jun 12)
- Bard Increases Quarterly DividendBusiness Wire(Wed, Jun 12)
- Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical TrialBusiness Wire(Tue, Jun 4)
Reports
- C. R. Bard, Inc.Datamonitor(Jun 18)
- BCR: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Jun 18)
- Thomson Reuters Stock Report - C.R. BARD INC (BCR-N)Thomson Reuters Stock Report(Jun 18)